Massachusetts General Hospital
At Issue: Publication of CABANA results prompts further debate over AF ablation
Prednisone tapering fails in most patients with giant cell arteritis

CHICAGO — The majority of patients with giant cell arteritis who are treated with prednisone are unsuccessful in tapering the drug, unless combined with tocilizumab, and more than 80% of disease-related flares occur while prednisone is still in use, according to data presented at the 2019 Interdisciplinary Autoimmune Summit.
Entinostat plus pembrolizumab shows efficacy in anti-PD-1-resistant melanoma

ATLANTA — The combination of the histone deacetylase inhibitor entinostat and the anti-PD-1 inhibitor pembrolizumab induced clinical responses and appeared well-tolerated among patients with melanoma that progressed on prior anti-PD-1 treatment, according to results from the single-arm ENCORE 601 phase 1b/phase 2 clinical trial presented at American Association of Cancer Research Annual Meeting.
Savolitinib, osimertinib combination may benefit certain patients with EGFR-mutated lung cancer

ATLANTA — The combination of savolitinib and osimertinib showed promising clinical activity among patients with EGFR-mutated non-small cell lung cancer resistant to prior EGFR-targeted therapies through MET amplification, according to interim results from two expansion cohorts of the TATTON trial presented at American Association for Cancer Research Annual Meeting.
American Association for Cancer Research announces president-elect
Common hospital discharge barriers to recognize
PANACHE: Neladenoson unsuccessful in improving walking distance in HFpEF

NEW ORLEANS —A partial adenosine A1 receptor agonist in patients with HF with preserved ejection fraction did not have a dose-response effect for 6-minute walk distance at 20 weeks and other endpoints such as activity levels, ECG monitoring and echocardiographic endpoints, according to data from the PANACHE trial presented at the American College of Cardiology Scientific Session.
VIDEO: Volar plates are not always suitable for patients with distal radius fractures
LAS VEGAS — At the American Academy of Orthopaedic Surgeons Annual Meeting, Jesse B. Jupiter, MD, discussed whether volar plating was enough for the treatment of distal radius fractures. He said volar plates are not always suitable or applicable for all patients with distal radius fractures and that additional technologies may be needed.